Second primary cancers after vulvar and vaginal cancers

Article Abstract:

Cigarette smoking may be prevalent among women who are diagnosed with second primary cancers of the vulva or vagina. The human papillomavirus (HPV), a sexually transmitted disease, may be the cause of genital cancers. Researchers analyzed 1349 cases of vaginal cancer and 5583 cases of vulvar cancer recorded by nine cancer registries to determine rates of second cancers. Women with vulvar or vaginal cancer were found to have increased risks of developing second cancers, as were women with cervical cancer, and these cancers were related to cigarette smoking. Second cancer rates ranged from 5% to 8%. Smoking cessation should be encouraged among patients diagnosed with vaginal and vulvar cancers. A diagnosis of vulvar cancer increased the risk of developing anal or cervical cancer, with HPV the common cause of all three.

Smoking and women, Women smokers, Vulvar cancer, Vaginal cancer

---

Cancer risk after a hospital discharge diagnosis of endometriosis

Article Abstract:

Women hospitalized for endometriosis may have an increased risk of breast, ovarian, and blood cell cancer. Endometriosis is a disorder in which menstrual tissue migrates out of the uterus and attaches itself to other organs. Researchers analyzed data on 20,686 Swedish women who were hospitalized because of endometriosis. These women had nearly a 20% greater risk of cancer than other Swedish women. Breast and ovarian cancers and cancers of the blood, especially non-Hodgkin's lymphoma, were more prevalent than other cancers. Endometriosis hormonal treatments may possibly be implicated in the higher risk of cancer.

Breast cancer, Ovarian cancer, Non-Hodgkin's lymphomas, Endometriosis

---

Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs

Article Abstract:

A study is undertaken to evaluate melanoma, thyroid, colon and cervical cancer risk after clomiphene or gonadotropins. Fertility drugs do not appear to have strong effects on these cancers, however, follow-up should be pursued to assess long-term risks and to monitor effects among women who remain nulliparous.

United States, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Fertility Preparations, Complications and side effects, Cervical cancer, Gonadotropin, Gonadotropins, Fertility agents, Fertility drugs, Thyroid cancer, Clomiphene, Colon cancer

Similar abstracts:

• Abstracts: Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Previous pregnancy loss: Risks related to severity of preterm delivery
• Abstracts: Erlotinib in lung cancer: Molecular and clinical predictors of outcome. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
• Abstracts: Treatment strategies for bacteria and viruses: Why clinical management must be different. Legionella bacteria and water systems in health care premises
• Abstracts: From catheters to vectors: the dawn of molecular electrophysiology. Genetic testing in the long QT syndrome: Development and validation of an efficient approach to genotyping in clinical practice

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.